Unapproved, compounded versions of a popular diabetes and weight-loss drug are being sold in Canada, the Ozempic maker said, amid a warning about dosing errors that have resulted in some people being hospitalized in the United States. Novo Nordisk told Global News on Monday that it has filed a complaint with …
Read More »
Asian Tribune Your Multilingual Newspaper covering World and local news News